Sunday, November 1, 2026

Banana Chip Recall: Excessive Pesticide Forces South Korean Ministry to Act

Korea's Ministry of Food and Drug Safety recalls banana chips due to excessive pesticide levels, urging consumers to return affected products.

How Medical Accident Disclosure Could Transform Patient Rights in South Korea

A patient with spinal surgery suffered paralysis due to a medical accident, raising concerns about informed consent in healthcare.

Down Fall of Elon Musk? Stocks Slide Amid CEO Pay Controversy

As the re-vote for Tesla CEO Elon...

Health

Unlock Your Health: Discover the New AI-Powered BioAge and Health Coach Services from DaNaA Data

Daewoo Group's AI health data firm, DaNaA Data, launched a service analyzing biological age, disease risk, and health check results.

How the New Medical School in Namwon Can Transform Regional Healthcare: Insights from Lawmaker Park Ji-won

Defining school locations alone won't solve local healthcare issues; deeper strategies are needed for effective solutions.

Ardens Lifescience Triumphs: How a Korean Startup Won 175,000 USD at MedTech Innovator APAC 2026

Adenz Life Sciences wins a global medical device competition, earning a prize of 175,000 USD.

Unlocking the Future of Healthcare: Daewoong’s AI-Powered Smart Hospital at AI EXPO MARS 2026

Daewoong Pharmaceutical introduces an AI-based smart hospital model for monitoring, diagnosis, testing, and rehabilitation.

10 Years of Excellence: Seoul’s APLAR Center Hosts International Rheumatology Training for Young Specialists

Seoul St. Mary's Hospital's Rheumatology Center held an international training program for foreign experts on October 27 and 26.
Latest

How Celltrion’s Omlyclo Achieved 16% Market Share in Europe: A Game-Changer for Biologics

Celltrion's biosimilars gain market share in Europe, with Omlyclo leading in Spain and Vegzelma maintaining strong presence amid competition.

Metabolic Surgery for Obese Seniors: A Safe Solution for Diabetes and Hypertension?

A study shows metabolic obesity surgery is safe for patients over 55, improving diabetes and other metabolic diseases effectively.

Belvarafenib: The Promising New Targeted Cancer Drug for NRAS Mutant Melanoma

Hanmi Pharmaceutical presents Belvarafenib's phase 2 trial for NRAS mutant melanoma at KCA 2026, targeting unmet medical needs.

Discover the New Turbineu Double Action Aerosol: The Ultimate Solution for Athlete’s Foot in 2026

Dong-A Pharmaceutical has launched 'Turbinew Double Action Aerosol', an easy-to-use spray treatment for athlete's foot.

Samsung Bioepis Signs Teva Deal to Commercialize Opuviz in Canada, Expanding North American Biosimilar Business

Samsung Bioepis partners with Teva to launch ophthalmology biosimilar Opuviz in Canada, enhancing access to treatments for patients.

Korea’s First CAR-T Therapy Clears Initial Reimbursement Hurdle, With First Prescriptions Expected in October

South Korea's first CAR-T therapy, Rimkato, moves closer to national health insurance reimbursement, with commercialization expected by year-end.

Interview: Huons’ PanGen Bets on ‘Development-Focused CDMO’ Strategy Built on Biosimilar Experience

South Korea's PanGen CDMO emphasizes development expertise and tailored services, enhancing drug development support for clients.

SK Bioscience Achieves WHO PQ Certification: What This Means for Global Vaccine Supply

SK Bioscience completed WHO's triennial review for its vaccines, enhancing international trust in its quality and operational systems.

Hospitals Fuel South Korea’s Stem Cell Treatment Boom, but Experts Call for Stronger Patient Safeguards

South Korea's stem cell therapies expand rapidly, but lack regulation and clinical evidence, raising patient concerns about treatment choices.

Seoul Asan Medical Center Surpasses 3,000 Adult ECMO Cases, With 65% Successfully Weaned From Life Support

Seoul Asan Medical Center has performed over 3,000 ECMO procedures, achieving a 65% weaning success rate for critically ill patients.

AI Model Predicts Liver Function Decline Before Liver Cancer Treatment, Enabling More Personalized Care

South Korean researchers created an AI model to predict liver function decline in cancer patients, enhancing treatment safety and effectiveness.

Lotte Biologics’ ‘Three Production Batches, 14% Utilization’ Underscores Need for New Orders Over New Plants

Lotte Biologics aims to enter the global CDMO market by expanding production, but faces challenges in securing contracts and profitability.

ABL Bio to Launch Global Phase 3 Trial of ABL111 in December, Targeting First-Line Gastric Cancer Treatment

ABL Bio will begin global Phase 3 trials for its dual antibody gastric cancer treatment 'ABL111' this December after FDA discussions.

2026 Residency Report: Why Reduced Working Hours Aren’t Improving Mental Health for Asian Doctors

Despite reduced working hours, medical residents face worsening mental health, highlighting a need for better training and support systems.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.